System online
Global AI waste / yr$847B
Avg per-employee spend$4,830
Recoverable in 90 days34%
Healthcare AI Governance

AI spend in healthcare
is under-governed.
We find the waste.
We install the controls.

Identify redundant tools, unused licenses, and avoidable AI spend — then build the governance structure to prevent recurrence.

No patient records required
No EHR access required
Initial findings typically within 30 days
// Waste Diagnostic — Healthcare v2.4.1
// Current state
avg_tools_per_system11.3
utilization_rate53%
roi_tracked27% of orgs
shadow_ai_spend+30–40%
// Recovery opportunity
recoverable_pct34%
audit_roi8–12×
timeline90 days
statusReady to audit
$4,830Per-employee AI spend / yr
34%Recoverable in 90 days
8–12×Typical audit ROI
90dStandard engagement
$4,830per-employee AI waste — Zylo 2024 47%of AI tools used less than monthly — Gartner $2.1Tglobal AI spend projected by 2028 — IDC 68%healthcare AI pilots fail to scale — McKinsey 34%recoverable in 90 days — Aitonoma benchmark $4,830per-employee AI waste — Zylo 2024 47%of AI tools used less than monthly — Gartner $2.1Tglobal AI spend projected by 2028 — IDC 68%healthcare AI pilots fail to scale — McKinsey 34%recoverable in 90 days — Aitonoma benchmark
Who This Is For

Built for organizations with
real AI spend and limited visibility.

Visibility

What you're paying for and whether it's actually being used.

Exposure

Where waste is accumulating and where controls are missing.

Action

What to renegotiate, consolidate, or shut down — documented and ready to execute.

The Problem

AI adoption outpaced governance.
That gap is now expensive.

Unused licenses, overlapping vendors, pilots that never matured — most organizations did not create AI sprawl intentionally. It accumulated.

Unused licenses accumulate quietly.

Department-level purchases persist long after adoption stalls. Contracts auto-renew. No one is accountable.

Pilots rarely stay contained.

Tools expand before governance catches up. Leadership moves on. The spend continues.

Vendor overlap is common.

Multiple tools solving the same problem across teams, with no consolidated inventory and no standard for selection.

Weak ownership drives repeat waste.

Without utilization review and renewal controls, waste recurs even after one-time cleanup. The structural problem persists.

Quantify your exposure before the next renewal.

Five questions. A directional estimate of annual AI waste, benchmarked against your sector.

See the Diagnostic →
The Engagement

Three phases.
Ninety days.
No ambiguity.

Phase 01 — Weeks 1–2
Full Inventory

We build a defensible picture of your AI and software footprint from contracts, invoices, usage data, and stakeholder interviews.

Output: footprint snapshot · key risks · audit scope
Phase 02 — Weeks 3–6
Waste & Value Analysis

We identify redundant vendors, unused licenses, and governance failures — then quantify financial exposure and recovery opportunity.

Output: vendor register · rationalization matrix · governance findings
Phase 03 — Weeks 7–12
Recovery Architecture

A practical plan covering what to cancel, consolidate, renegotiate, and keep — with controls installed to prevent recurrence.

Output: savings waterfall · 90-day action plan · executive readout
The Platform

Every signal. Every dollar at risk.

The Aitonoma dashboard scores dollar impact, diagnoses root cause, and queues fixes — ranked by what it costs you to wait.

Aitonoma Command Center — action queue ranked by dollar impact
Real-time scoring

Every signal scored by dollar impact, not just severity label.

Root cause + fix plan

AI diagnoses cause and writes numbered remediation steps.

Human approval gate

Nothing executes without your sign-off.

What You Receive

Not commentary.
Operating outputs.

01
Inventory Map

Vendors, contracts, owners, spend, and tool purpose — structured and documented. For most organizations, this does not exist before we build it.

02
Waste Analysis

Quantified review of duplication, underuse, and avoidable spend — broken down by category and prioritized by recovery opportunity.

03
Recovery Plan

Prioritized action list of cancellations, renegotiations, and consolidations — sequenced by savings, effort, and contract timing.

04
Governance Framework

Decision rights, renewal checkpoints, and oversight mechanisms built to prevent recurrence.

05
Executive Readout

Board- and leadership-ready summary of findings, risks, and implementation priorities. Designed for CFO and C-suite presentation.

06
Optional Advisory Continuity

Ongoing monthly support for vendor actions, savings validation, and governance rollout — available to completed audit clients.

Engagement Structure

Fixed fee.
No hourly overrun.
No open-ended commitment.

Scoped, priced, and delivered against business value — not billable-hour drift.

Smaller organizations · focused reviews
Rapid Audit
$25,000
Fixed fee · 30-day engagement
  • Up to 10 core tools
  • AI portfolio scan
  • Spend and overlap review
  • Recovery opportunities identified
  • Governance gap snapshot
  • Executive readout
Request a Proposal →
Health systems · regulated entities · multi-site
Enterprise
$175,000+
Scoped engagement · 90–180 days
  • 1,000+ employees
  • Enterprise-wide audit across departments and sites
  • Advanced spend, workflow, and vendor analysis
  • Board-ready reporting and presentation support
  • Controls architecture and governance design
  • Cross-functional remediation planning
  • C-suite and executive advisory
  • Implementation partnership available
Inquire →
Why fixed fee

We do not bill by the hour because the value is known before the work begins. A $75,000 engagement that surfaces recoverable waste and installs controls is a capital decision with measurable return — not consulting overhead.

Ongoing advisory

For organizations that want hands-on execution support after the audit — vendor action, savings validation, procurement reform, and governance rollout — available on a monthly basis.

Why Aitonoma

Most consultants understand strategy.
Most IT firms understand tools.
Few understand both.

Aitonoma works at the intersection of healthcare operations, AI governance, vendor economics, and executive accountability — connecting procurement reality with governance design.

PHOTO

"High-value AI contracts are often renewed without the data, controls, or visibility required to evaluate them properly. That is not a technology problem. It is a governance problem. Aitonoma exists to solve it."

Dr. Akua Agyeman
Founder · Physician · Healthcare AI Governance Advisor
Questions

On the engagement.

How is this different from a standard IT audit?
This is not a hardware review, security assessment, or general systems audit. We focus on one specific problem: AI tools that organizations pay for but cannot account for. The output is a capital decision with a documented return — not a compliance report.
What do you need access to?
A vendor list, available spend and contract data, and structured interviews with three to five department leads. We do not require access to patient records, clinical systems, or EHR environments.
What if we cannot produce a complete tool inventory?
That is the standard condition. Phase 1 exists precisely to surface what your procurement team does not have visibility into. Shadow spend and ungoverned contracts are the norm, not the exception.
What is Discovery, and when does it make sense?
Discovery is a one-to-two week scoping engagement. It produces a footprint snapshot, a preliminary waste hypothesis, and a formal audit scope memo — designed to give both parties the clarity needed before a full engagement.
When do results materialize?
Immediate review candidates — unused licenses, redundant subscriptions — surface early in the engagement. The full recovery plan targets recovery of identifiable waste within 90 days of completion.
Do you support implementation?
Yes. Ongoing monthly advisory is available for organizations that need execution support after the audit — vendor consolidation, controls rollout, procurement reform, and savings verification.
Why not have our internal team do this?
Internal teams usually lack the time, neutrality, or cross-functional mandate to surface what AI portfolios are actually costing. Aitonoma provides the outside view that produces honest numbers.
Engage

If the numbers concern you,
we should talk.

If your organization lacks a clear inventory, utilization visibility, or renewal discipline — the issue is already costing you.